The p53 Family Protein p73 Provides New Insights into Cancer Chemosensitivity and Targeting
Autor: | Paolo Lunghi, Antonio Bonati, Vittorio Rizzoli, Antonio Costanzo, Massimo Levrero, Laura Mazzera |
---|---|
Rok vydání: | 2009 |
Předmět: |
Cancer Research
Programmed cell death Mutation Tumor Suppressor Protein p53 Neoplasms Tumor Suppressor Proteins Drug Delivery Systems DNA-Binding Proteins Humans Apoptosis Nuclear Proteins Protein Isoforms Drug Resistance Neoplasm Models Biological Drug Design Mutant Drug Resistance Biology medicine.disease_cause Models medicine Tumor Protein p73 skin and connective tissue diseases neoplasms Genetics Settore MED/35 - Malattie Cutanee e Veneree Cancer Apoptosis DNA-Binding Proteins antagonists /&/ inhibitors/metabolism Drug Delivery Systems Drug Design Drug Resistance Neoplasm Humans Models Biological Mutation Neoplasms dr/ug therapy/metabolism Nuclear Proteins antagonists /&/ inhibitors/metabolism Protein Isoforms metabolism Tumor Suppressor Protein p53 metabolism Tumor Suppressor Proteins antagonists /&/ inhibitors/metabolism Biological medicine.disease Oncology Acetylation Cancer research Neoplasm Phosphorylation |
Zdroj: | Clinical Cancer Research. 15:6495-6502 |
ISSN: | 1557-3265 1078-0432 |
Popis: | The p53 tumor suppressor is part of a small family of related proteins that includes two other members, p73 and p63. Interest in the p53 family members, their functions and their complex interactions and regulation, has steadily grown over recent years and does not show signs of waning. p73 is a major determinant of chemosensitivity in humans, and mutant p53 proteins carrying specific polymorphisms can induce drug resistance by inhibiting TAp73. Cooperation between TA (transactivating, proapoptotic, antiproliferative) and ΔN (truncated, antiapoptotic, pro-proliferative) p73 isoforms and among the three family members guarantees equilibrium between proliferation, differentiation, and cell death, thus creating a harmony that is lost in several human cancers. In this article, we review our current knowledge of the role of p73 in cancer chemosensitivity and the real prospect of therapy targeting this molecule. We also draw attention to the crucial role of specific phosphorylation and acetylation events for p73-induced apoptosis and drug chemosensitivity. (Clin Cancer Res 2009;15(21):6495–502) |
Databáze: | OpenAIRE |
Externí odkaz: |